| Field | Specification |
|---|---|
| Mfr No | |
| Activity | |
| Alternative Names | 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, ethyl ester; Ro 1722; Ro 15-1788 |
| Cas No. | |
| Form | White powder |
| Molecular Weight | |
| Product Type | |
| Purity | |
| Shipping | |
| SMILES | |
| Solubility | May be dissolved in DMSO (8 mg/ml) |
| Source | Synthetic |
| Storage |
Flumazenil is a benzodiazepine antagonist that binds to GABA_A receptors containing α1, α2, α3, or α5 subunits. It is clinically used to reverse benzodiazepine-induced sedation and toxicity. In neurodegenerative disease research, Flumazenil is studied for its effects on GABAergic signaling, withdrawal syndromes, and its potential to modulate cognitive and behavioral outcomes in CNS disorders.
Classification: Caution- Substance not yet fully tested.
Safety Phrases:
- S22 - Do not breathe dust
- S36/37/39 - Wear suitable protective clothing, gloves and eye/face protection
- S24/25- Avoid contact with skin and eyes
Flumazenil (StressMarq Biosciences Inc., Victoria BC CANADA, Catalog # SIH-622)
Need this compound in a format that drops straight into your assay? We can tailor formulation, chemistry, and documentation so your results stay consistent across runs and re-orders.
- Format options: solid or pre-dissolved solution (choose solvent), target concentration, aliquots, light/moisture-protected packaging
- Chemistry options: free base/acid vs salt forms, hydrate/solvate preference, stereoisomer control (single enantiomer or racemate), close analogs
- Add-on labels & handles: D/¹³C/¹⁵N isotopes (LC-MS/internal standards), azide/alkyne or other functional handles for conjugation
- QC & documentation: standard COA or enhanced analytical pack (HPLC/LC-MS/NMR), chiral purity, residual solvents, water content (KF), method-specific specs
- Scale & continuity: mg to gram scale, bulk pricing, lot reservation, repeat-order continuity
To quote quickly, tell us: compound name + CAS/structure (SMILES or mol file), intended assay context, solvent preference, salt/stereochemistry requirements, purity/QC level, and the amount (mg–g).
Can’t find the compound you’re looking for?
Send the CAS or structure and your specs. We can help source it, suggest close
equivalents, or discuss custom synthesis with the right QC documentation (RUO).
2. Doble A., (1999) J. Psychopharmacol. 13(4 Suppl 1):S11.
3. Hood SD., et al. (2014) Br. J. Clin. Pharmacol. 77:285.
4. Lheureux P., et al.(1990) Hum. Exp. Toxicol. 9:105.
5. Masciullo M., et al. (2021) J. Med. Case Rep. 15:242.